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Sonia M. Parnell,{ Graham Anderson,{ Susan M. Kaech,# and Valerie Horsley*,**
Autoimmunity is largely prevented by medullary thymic epithelial cells (TECs) through their expression and presentation of tissue-
specific Ags to developing thymocytes, resulting in deletion of self-reactive T cells and supporting regulatory T cell development. The
transcription factor Prdm1 has been implicated in autoimmune diseases in humans through genome-wide association studies and
in mice using cell type–specific deletion of Prdm1 in T and dendritic cells. In this article, we demonstrate that Prdm1 functions in
TECs to prevent autoimmunity in mice. Prdm1 is expressed by a subset of mouse TECs, and conditional deletion of Prdm1 in
either Keratin 14– or Foxn1-expressing cells in mice resulted in multisymptom autoimmune pathology. Notably, the development
of Foxp3+ regulatory T cells occurs normally in the absence of Blimp1. Importantly, nude mice developed anti-nuclear Abs when
transplanted with Prdm1 null TECs, but not wild-type TECs, indicating that Prdm1 functions in TECs to regulate autoantibody
production. We show that Prdm1 acts independently of Aire, a crucial transcription factor implicated in medullary TEC function.
Collectively, our data highlight a previously unrecognized role for Prdm1 in regulating thymic epithelial function. The Journal of
Immunology, 2017, 199: 1250–1260.
T
he thymus is essential for the prevention of autoimmunity
through the induction of T cell tolerance and the gener-
ation of FoxP3+ regulatory T cells (Tregs). Thymocytes
expressing a functional TCR are positively selected by interacting
with cortical thymic epithelial cells (TECs) (cTECs), after which
they migrate and interact with tissue-specific Ags (TSAs) pre-
sented on medullary TECs (mTECs) and dendritic cells. Recog-
nition of TSAs results in negative selection, whereby autoreactive
T cells are eliminated (1–4). Although little is known about the
precise mechanisms that control TSA expression in TECs, the
transcription factor autoimmune regulator (Aire) is central to TSA
expression (5). Aire can bind to the repressive MBD1-ATF7ip
complex, which methylates CpG dinucleotides to target specific
TSA genomic loci. Aire also recruits proteins that promote tran-
scriptional elongation and pre-mRNA processing (6). However,
additional molecular players that alter the epigenetic landscape to
enable the full function of Aire have yet to be fully elucidated.
Furthermore, whereas Aire ensures that self-antigens are expressed
within the thymus in mTECs (5, 7), several Aire-independent self-
antigens are expressed within the thymus (8, 9), and each self-
antigen is expressed by a low percentage of mTECs, (1) suggesting
that multiple mechanisms exist to regulate mTEC function.
Prdm1 (Blimp1) is a transcription factor that controls gene
expression and chromatin structure in several embryonic and adult
tissues. Prdm1 acts as a transcriptional repressor by binding to
DNA through its proline-rich zinc finger domain and recruiting
transcriptional cofactors such as hGroucho, histone deacetylases
(HDACs), and histone methyltransferases (10–14). In differenti-
ating plasma cells, Prdm1 represses genes involved in B cell
maturation and proliferation (15, 16), mediating terminal differ-
entiation (15, 17, 18). Prdm1 also controls gene expression pat-
terns in many lymphocytes and myeloid cells, including dendritic
cells (19), macrophages (20), T cells (21, 22), and NK cells (23).
Beyond the immune system, Prdm1 has numerous roles in
regulating epithelial development. In the intestinal epithelium,
Prdm1 controls multiple aspects of the neonatal-to-adult transition
(24, 25), namely terminal differentiation of the skin epidermis (26)
and sebocyte progenitor cell function (27).
Given the similarities between skin and the thymic epithelium
(28–30) and the models used to describe the roles of skin in-
flammation with age in Prdm1 conditional knockout (KO) (cKO)
mice (31, 32), we sought to determine whether Prdm1 influences
thymic epithelial function. In this study, we identified and mapped
the expression of Prdm1 to the thymus medulla. In addition, we
have shown that Prdm1 is expressed in TECs and that mice
lacking Prdm1 in either keratin-14 (K14)- or FoxN1-expressing
epithelial cells generate self-reactive Abs and develop several
autoimmune phenotypes. These phenotypes in mice lacking Prdm1
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in epithelium are not due to defects in the development of CD4,
CD8, or Foxp3+ Tregs. In fact, by performing thymus transplan-
tation experiments into nude mice, we demonstrated that Prdm1-
deficient mTECs are sufficient to induce autoimmunity. Together,
our findings implicate Prdm1 in the regulation of autoimmunity in
TECs and are consistent with the identification of polymorphisms
in Prdm1 associated with autoimmune diseases, such as systemic
lupus erythematosus (SLE) (33, 34).
Materials and Methods
Animal use
All animals were housed and handled according to the institutional guidelines
of Yale University. Keratin14-Cre (35), Prdm1-floxed (27), Prdm1-eGFP
(36), Prdm1-YFP (37), mTmG (38), Aire KO (39), and FoxN1-Cre (40) mice
were previously described. MRL/Faslpr (MRL/MpJ-Faslpr/2J) animals were
purchased from The Jackson Laboratory (41).
For Prdm1fl/fl;K14Cre, Prdm1fl/fl;FoxN1Cre, Prdm1eGFP, and Prdm1YFP,
mice were maintained in the inbred C57BL/6 background, and age-matched
Prdm1fl/+;Cre+ littermates were used as controls. For the K14Cre;mTmG
and FoxN1Cre;mTmG lineage tracing experiments, mice were in a mixed
C57BL/6,129X1/SvJ background. Control mice for all experiments were
Prdm1fl/+;K14Cre+ age-matched littermates because these mice did not de-
velop the initial ventral alopecia and dermatitis.
Cell isolation
Thymocyte, splenocyte, and lymph node suspensions were obtained from
adult organs by mechanical dissociation. Stromal cells from adult thymi
were isolated, as previously described (42). In brief, thymus lobes were cut
into 1-mm3 pieces, washed, and digested with R-5 medium (L-glutamine–
supplemented RPMI 1640 [Sigma-Aldrich], 10 mM HEPES [Life Tech-
nologies, Invitrogen], 5% FCS) containing 0.32 Wunsch U/ml Liberase/
thermolysin (Roche) and 50 Kunitz U/ml21 DNase I (Sigma-Aldrich) at
37˚C for 40 min using a gyratory water bath shaker (New Brunswick
Scientific). Enzymatic treatment was repeated for an additional 20 min,
followed by incubation with 5 mM EDTA on ice for 10 min. Remaining
tissue fragments were mechanically dispersed by careful pipetting. Cell
suspensions from each digestion were pooled and washed in ice-cold PBS
containing 2% FCS and 2 mM EDTA to prevent aggregate formation.
Stromal cells were enriched by MACS immunomagnetic depletion of
CD45+ cells (Miltenyi Biotec), according to the manufacturer’s protocol.
Cell surface Ab staining was performed in 2% FCS and 2 mM EDTA to
prevent aggregate formation.
Immunofluorescence of tissues
Wild-type (WT) tissues were embedded in OCT compound (Tissue-Tek),
frozen using dry ice, and 6-mm sections were cut and fixed in 100% ac-
etone (4˚C, 20 min). Thymus samples from Prdm1-GFP mice were fixed in
3.7% formaldehyde in PBS for 1 h at room temperature (RT), washed
twice in PBS, and placed consecutively in 10% sucrose overnight at 4˚C,
20% sucrose overnight at 4˚C, and 30% sucrose overnight at 4˚C, before
embedding in OCT compound, and sectioned. Tissue sections were incu-
bated with primary Abs for 40 min and washed in PBS before incubating
in secondary (and/or tertiary) Abs for 30 min. Slides were washed in PBS
three times before staining with DAPI (Pierce) and mounting with Prolong
Gold anti-fade reagent (Life Technologies, Grand Island, NY). Images
were acquired using Zeiss Imager M.1 fluorescent microscope (Zeiss,
Oberkochen, Germany) with AxioCam MR3 camera and AxioVision (re-
lease 4.8.2) software.
Abs used were as follows: primary Abs, IgG (poly4053) DyLight 488,
IgM (RMM-1) biotinylated (BioLegend), Keratin 5 (gift from Julie Segre),
Keratin 8 (Progen) biotinylated, goat anti-Aire (D17) (Santa Cruz Bio-
technology), rabbit anti-Involucrin (gift from Julie Segre); secondary Abs,
donkey anti-chicken 488 (Invitrogen), chicken anti-GFP 488 (Abcam), anti-
mouse IgG FITC (Southern Biotechnology), anti-mouse IgG biotinylated
(Vector Laboratories), anti-goat Rhodamine Red-X (Jackson Immuno-
Research), and goat anti-rabbit Alexa Fluor 647 (Life Technologies). Bio-
tinylated Abs were picked up with Alexa Fluor 555–conjugated streptavidin
(Invitrogen).
Prdm1 immunohistochemistry
Normal human thymus (use of human tissue approved by National Re-
search Ethics Service/Research Ethics Committee reference: 07/Q1206/
47) stained rabbit anti-PRDM1 polyclonal Ab R23 (14, 27, 43) with
heat-mediated Ag retrieval was used, with standard streptavidin Avidin-
Biotin Complex immunocytochemistry and 3,39-diaminobenzidine as
the chromogen. We obtained 403 magnification using an Olympus BX50
microscope (Olympus, Tokyo, Japan), a Plan Apo 403/0.95 objective lens
(Tokyo, Japan), a Leica DFC-320 digital camera (Leica, Solms, Germany),
and associated Leica IM50 software.
Anti-nuclear Ab staining
A 1:40 dilution of the serum samples isolated from Prdm1fl/fl;K14Cre and
Prdm1fl/+;K14Cre mice or from nude hosts grafted with embryonic thymus
isolated from Prdm1fl/fl;K14Cre and Prdm1fl/+;K14Cremice were incubated
for 30 min at RT on 12 spot anti-nuclear Ab (ANA) diagnostic HEp2 Slides
(Bio-Rad). Serum isolated from MRL/Faslpr mice was used as an ANA-
positive control (41). FITC anti-mouse secondary Ab (Southern Biotech-
nology), diluted 1:50 in 0.1% BSA/PBS, was used for detection. Coverslips
were mounted using Fluoromount.
Images were acquired using a Zeiss LSM 510 confocal microscope
(Zeiss) equipped with a 403 Plan-Apochromat objective. Image acquisi-
tion and processing were performed using ZEN software.
Flow cytometry and FACS
For flow cytometry single-cell thymocyte, splenocyte, and lymph node,
suspensions were stained with the following Abs: anti-CD80 (16-10A1)
FITC, CD80 (B7-1) PerCP-eFluor710, anti-CD45 (30F11) PE, TCR b-chain
(TCRb; H57-597) biotinylated, CD8 (53-6.7) allophycocyanin, CD44 (IM7)
Alexa Fluor 450, CD62L (MEL-14) allophycocyanin 780, FoxP3 (FJK-16s)
Alexa Fluor 647, CD4 (RM4-5) allophycocyanin Cy7, CD25 (PC61.5) Alexa
Fluor 488, anti–BP-1/Ly51 (6C3) biotinylated, MHC class II (MHCII; I-A/I-E)
clone M5/114.15.2 eFluor450 (all eBioscience), and CD4 (GK1.5) PerCP
(BioLegend). Anti-EPCAM1 (G8.8) (BD Pharmingen) was directly conju-
gated using the Alexa Fluor 647 mAb Labeling Kit (Invitrogen) according to
the manufacturer’s instructions. Biotinylated Abs were picked up with either
PE-Cy7–conjugated streptavidin or allophycocyanin-conjugated streptavidin
(BD Biosciences). For intracellular staining of Foxp3, cells were fixed and
permeabilized using the Foxp3 fixation and permeabilization concentrate
and diluent set (eBioscience) according to the manufacturer’s protocol and
stained with anti-Foxp3 647 (clone FJK-16s; eBioscience). For RNA iso-
lation, the populations were sorted directly into TRIzol LS (Life Technolo-
gies). Given the low number of mTECs, mTECs were sorted and pooled
from up to 10 mice to analyze mRNA expression in mTEC populations.
Cells were analyzed or sorted using a FACSAria III equipped with
FACSDiva software (BD Biosciences).
Fetal thymus organ culture and thymus grafting
Embryonic day (E) 15 fetal thymuses were isolated from Prdm1fl/fl;
K14Cre+ and Prdm1fl/+;K14Cre+ (control) embryos. Fetal thymic organ
cultures were prepared as described previously (44), cultured in the pres-
ence of 1.35 mM 2-deoxyguanosine monohydrate (Sigma) for 7 d, and
used as thymus tissue for transplantation under the kidney capsule of adult
(6–8 wk) male Nude recipients (5).
ELISA
Ab isotypes were measured by ELISA using serum isolated from Prdm1fl/fl;
K14Cre+ and Prdm1fl/+;K14Cre+ mice or from nude hosts grafted with
embryonic (E15) thymus isolated from Prdm1fl/fl;K14Cre+ and Prdm1fl/+;
K14Cre+ mice. Ninety-six-well Polysorp microtiter plates (Nunc) were
coated overnight with a 9:1 ratio mixture of anti-k: anti-l (3 mg/ml)
(Southern Biotechnology) in 0.1 M Na2HPO4/NaH2PO4 (pH 9). Subse-
quently, a 1:200,000 dilution of sera was incubated for 2 h at RT. Alkaline
phosphatase–labeled goat anti-mouse IgG1, IgG2a, IgG2b, IgG3, IgE, or
IgM secondary Abs were used for detection (Southern Biotechnology).
The optical densities were converted to units based on standard curves with
Mouse Ig Panel Kit of IgG1, IgG2a, IgG2b, IgG3, IgM, and IgE (Southern
Biotechnology) using a four-parameter logistic equation (Softmax Pro 3.1
software; Molecular Devices).
RNA sequencing data analysis
Bioinformatic analysis and identification of Prdm1-related genes were
derived from the Brennecke (45) dataset (E-MTAB-3346 and E-MTAB-
3624 within ArrayExpress; https://www.ebi.ac.uk/arrayexpress/), which
contains single-cell transcriptome analysis of mTECs. From this previ-
ously normalized single-cell RNA-sequencing dataset, cells with any de-
tectable Prdm1 transcript levels were classified as Prdm1+ cells. All 36,017
genes from the 105-bp paired-end Illumina HiSEquation 2500 sequencing
analysis served as the input for Gene Set Enrichment Analysis (46).
Standard Gene Set Enrichment Analysis heat-map test was performed, and
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the top 50 Prdm1-associated features are displayed. Spearman-rank cor-
relations for Prdm1 were obtained for each gene across all 200 cells, and
resultant rho values were plotted as a bar graph. Statistical computations
were performed using WinStat 2014 (R. Fitch Software, Bad Krozingen,
Germany). The p values obtained from this analysis were tabulated and
plotted in Plotly. All genes associated with Prdm1 with an a cutoff of
0.0005 are reported. Additional analysis was performed whereby Aire-
dependent and Aire-independent gene sets identified by Sansom et al.
(47) (GSE53111 within the National Center for Biotechnology Information
Gene Expression Omnibus; http://www.ncbi.nlm.nih.gov/geo/) and Brennecke
et al. (45) were analyzed for associations with Prdm1. Box and whisker
plots were generated to describe the median Spearman-rank rho values for
Prdm1 to Aire-dependent, Aire-independent, and all gene sets.
Statistical analysis
Analyses were performed using GraphPad Prism version for Macintosh
(GraphPad Software, La Jolla, CA). Categorical data were analyzed using
Fisher exact test, whereas noncategorical data between two groups were
analyzed using a Mann–Whitney U test and a nonparametric test that does
not assume a normal distribution; noncategorical data between multiple
groups were compared using one-way ANOVA.
Results
Epithelial deletion of Prdm1 results in autoimmunity
Previous studies have established a role for Prdm1 in barrier epi-
thelial tissues, namely the skin and intestine (24, 27, 31, 32), but a
role within thymic epithelium remained unexplored. Mice lacking
Prdm1 in squamous epithelial cells were generated by crossing
Prdm1fl/fl mice (27) to mice expressing Cre recombinase driven by
the K14 promoter (Prdm1 cKOK14) (35) or the forkhead/winged-
helix box protein N1 (FoxN1) promoter (Prdm1 cKOFoxN1) (40).
Interestingly, in contrast with WT or heterozygous littermates,
∼80% of Prdm1 cKOK14 mice stochastically developed mandib-
ular and accessory mandibular cervical lymphadenopathy as they
aged ($2 mo) (Fig. 1A–C). Similarly, 100% of Prdm1 cKOFoxN1
mice analyzed developed lymphadenopathy, albeit at a slightly
later time point ($5 mo) (Supplemental Fig. 1A, 1B). Further
investigation of the immunological phenotype in Prdm1 cKOK14
mice revealed a significant infiltration of activated T lymphocytes
in their cervical lymph nodes compared with littermate control mice
(Fig. 1D, 1E), with Prdm1 cKOFoxN1 mice following the same trend
(Supplemental Fig. 1C, 1D). Interestingly, the lymphadenopathy
observed in these mice was not systemic, as suggested by the ab-
sence of significant splenomegaly (Supplemental Fig. 1E–G).
Given the similarities in phenotypes between the deletion of
Prdm1 with K14- and FoxN1-Cre mice, we sought to confirm that
Cre recombinase was active in the thymus of K14-Cre mice. To
this end, we crossed K14-Cre mice with the membrane tomato/
membrane GFP (mT/mG) reporter line, which induces mG expres-
sion after Cre-mediated recombination in K14-expressing cells (38).
Flow cytometric analysis of mTEC and cTEC cell populations
(Supplemental Fig. 2A) revealed the expression of mG in both
mTEC and cTECs (Supplemental Fig. 2B–E), indicating the activity
of Cre recombinase within the thymus of K14-Cre mice. Although
the absolute cell number of GFP+ cells tended to be greater in
mTECs compared with cTECs, this was not significantly different
(Supplemental Fig. 2D), and on average the proportion of GFP+
cells in mTECs and cTECs was comparable (Supplemental Fig. 2E).
Because both K14-Cre and FoxN1-Cre are active in TECs (40),
we hypothesized that activation of T cells observed in Prdm1
cKOK14 and Prdm1 cKOFoxN1 mice may be because of a break-
down in central tolerance. Consequently, we sought to examine
whether Prdm1 cKOK14 displayed characteristics of autoimmunity,
such as the presence of autoantibodies (48, 49). The sera of 80%
of Prdm1 cKOK14 (Fig. 1F, 1G) and 100% of Prdm1 cKOFoxN1
(Supplemental Fig. 1H) mice positively stained HEp2 cells with a
nuclear pattern, whereas only ∼20% of control mice displayed
ANA staining (Fig. 1G). The positive staining in Prdm1 cKOK14
mice exhibited a range of antinuclear patterns (50) with homoge-
nous and speckled patterns being most prevalent (Fig. 1H). Inter-
estingly, this was observed in this particular model only. Analysis
of total serum Ig levels by ELISA revealed normal levels of IgM
and IgG3 in control versus Prdm1 cKOK14 mice, whereas IgG1 and
IgG2b levels were significantly higher in the blood of Prdm1
cKOK14 mice (Fig. 1I). Moreover, Prdm1 cKOK14 mice displayed
deposits of IgG in their kidneys (Fig. 1J, 1K). Together, these data
demonstrate that the absence of Prdm1 in epithelial cells leads to
the development of spontaneous autoimmune-like disease and T cell
activation.
Prdm1 is expressed in TECs
Because the conditional deletion of Prdm1 from TECs results in
autoimmune-like pathology and TECs are pivotal in establishing
central tolerance, we next sought to determine whether Prdm1 was
expressed in TECs. Indeed, published microarray and RNA se-
quencing experiments demonstrated the presence of Prdm1 mRNA
expression in purified mTECs (GDS1655 and GSE70798) (51, 52).
To quantify the percentage of TECs that express Prdm1, we used
flow cytometry of isolated TECs from a mouse model expressing
YFP driven by the Prdm1 promoter (37). Thymi from Prdm1-YFP
mice (6–8 wk of age) were enzymatically dissociated, and the
resulting single-cell suspensions were stained with Abs against
EPCAM1, Ly51, MHCII, and CD80 and analyzed by flow
cytometry (42, 53) (Fig. 2A–E). mTECs were identified as CD452,
EPCAM1+, Ly51lo epithelial cells, whereas cTECs were identified
as CD452, EPCAM1+, Ly51hi cells (Fig. 2B). The mTEC pop-
ulation was dissected further as mTEClo and mTEChi based on
MHCII and CD80 expression levels (Fig. 2C). Although control
mice displayed no detectable YFP expression (data not shown), a
small percentage of cTECs were YFP+ (Fig. 2D). Interestingly, YFP
was not detected in mTEClo cells, whereas YFP was detected in a
proportion of mTEChi cells. Quantification of the percentage of
YFP+ cells in multiple mice revealed a significantly higher per-
centage of mTEChi cells (∼9%) were YFP+, compared with ∼2% of
YFP+ cTECs (Fig. 2E).
To further determine the expression of Prdm1 within TECs, we
analyzed thymi from a reporter mouse line that expressed
membrane-localized GFP (mGFP) driven by Prdm1 promoter (36).
Immunofluorescence staining of adult thymi from the Prdm1-mGFP
reporter line with Abs against K5, or involucrin, revealed expression
of GFP in a subset of TECs (Fig. 2F, 2G); both K5+ and involucrin+
cells expressing mGFP were identified (54).
To explore whether Prdm1 was expressed in human TECs, we
immunostained sections of human thymuswithAbs against PRDM1.
PRDM1+ nuclei were identified in human Hassall’s corpuscles
(Fig. 2H, arrows) (55) with a comparable staining pattern to that
seen within human epidermis used as the staining control (Fig. 2I)
(27). Together, these data are consistent with the expression of
Prdm1 in K5+ cells in mouse thymus, within Hassall’s corpuscles
in mouse and human thymus, and suggest that Prdm1 is expressed
in mature mTECs.
Prdm1 does not regulate TEC or T cell development
Given the autoimmune pathology in Prdm1 cKOK14 mice, the
expression of Prdm1 in TECs, and the Cre activity in K14-Cre
mice, we hypothesized that Prdm1 may regulate TEC develop-
ment or function. To identify whether TECs developed normally
in Prdm1 cKOK14 mice, we analyzed control and Prdm1 cKOK14
TECs by flow cytometry for the expression of EPCAM1, Ly51,
CD80, and MHCII to examine TEC maturation (42, 53) (Fig. 3A).
cTECs (EPCAM1+ Ly51hi), immature mTECs (EPCAM1+ Ly51lo
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FIGURE 1. Conditional deletion of Prdm1 in K14+ epithelium results in spontaneous development of autoimmunity. (A) Quantification of cervical
lymphadenopathy presentation in controlK14 (n = 35) and Prdm1 cKOK14 (n = 51). (B) Images of mandibular cervical lymphadenopathy in Prdm1 cKOK14
mice compared with the normal nodes of control mice. Scale bar, 10 mm. (C) Total lymphocyte numbers are elevated in Prdm1 cKOK14 and Prdm1
cKOFoxN1 mandibular and accessory mandibular cervical lymph nodes. (D) Flow cytometric analysis of CD4 T cells isolated from cervical (mandibular and
accessory mandibular) lymph nodes shows an increase in proportion of CD44+CD62L2 activated CD4 T cells. (E) An increase in CD44+CD62L2 activated
CD4 and CD8 T cells from Prdm1 cKOK14 cervical (mandibular and accessory mandibular) lymph nodes compared with control. (F) Serum isolated from
Prdm1 cKOK14 mice contains ANAs indicated by positive staining of HEp2 cells. Positive control is MRL/Faslpr mouse serum; negative control is sec-
ondary Ab alone. Scale bar, 50 mm. (G) The presence of ANAs is significantly more frequent in Prdm1 cKOK14 than in control. (H) Quantification of nuclear
patterns identified in sera derived from Prdm1 cKOK14 mice. (I) ELISA of serum Ab isotypes. Note IgG2b and IgG1 are significantly increased in Prdm1
cKOK14 serum. (J) Representative images of Prdm1 cKOK14 kidney sections exhibit more intense IgG staining than those of control mice. Scale bar, 25 mm.
(K) The presence of IgG is significantly more frequent in Prdm1 cKOK14 mice than in control. Data are mean 6 SEM. n $ 8 (C), n $ 5 (D and E), n $ 13
(F–H), n $ 15 (I), and n $ 3 (J) for each genotype. *p , 0.05, **p , 0.01, ***p , 0.001.
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MHCIIlo CD80lo), and mature mTECs (EPCAM1+ Ly51lo
MHCIIhi CD80hi) were present in Prdm1 cKOK14 at similar cell
numbers compared with littermate control mice (Fig. 3B–D). Simi-
larly, thymi from Prdm1 cKOFoxN1 mice and control mice displayed
similar numbers of cTEC and mTEC populations (Supplemental
Fig. 2F–I). Crucially, the levels of MHCII expression were com-
parable between control and Prdm1 cKOK14 mTECs (Fig. 3A, 3E,
3F). Furthermore, the gross thymic architecture was unaltered in
the absence of Prdm1 (Fig. 3E).
To further confirm that development of the mTEC compart-
ment was normal in the absence of Prdm1, we investigated Aire
expression in Prdm1 cKOK14 mice. Similar numbers of K5+, Aire+
cells were present in sections of Prdm1 cKOK14 thymi compared
with littermate controls (Fig. 3G, 3H). In addition, the level of
Aire mRNA expression was comparable between littermate con-
trol and Prdm1 cKOK14 mice mTECs (Fig. 3I).
To investigate whether T cell development was impaired in the
absence of Prdm1, we isolated thymocytes from control and
Prdm1 cKOK14 mice or Prdm1 cKOFoxN1 mice, stained them for
CD4, CD8, and TCRb, and analyzed them by flow cytometry.
Both control and Prdm1 cKOK14 mice displayed typical CD4 and
CD8 profiles (Fig. 3J) and cell numbers (Fig. 3K), suggesting
FIGURE 2. Expression of Prdm1 in the mouse thymus. (A) Representative flow cytometry plots indicating the gating strategy for the CD452 EPCAM1+
epithelium, (B) cTEC (Ly51+EPCAM1+), mTEC (Ly512EPCAM1+), (C) mTEClo (Ly512EPCAM1+CD802MHCIIlo), and mTEChi (Ly512EPCAM1+
CD80+MHCIIhi) for Prdm1-YFP mice. (D) Representative flow cytometry plots indicating the YFP expression within the populations shown in (A). (E)
Quantification of the percentage of YFP+ cells for each of the indicated epithelial cell populations. Data are mean6 SEM. n = 5 mice. (F and G) Sections of
the thymus from Prdm1-mGFP mice reveal expression of mGFP in K5+ and involucrin+ cells in the medulla. (H) Human thymus sections illustrating Prdm1
expression within mTECs and TECs within Hassles corpuscles. (I) Sections from human skin epithelium illustrating positive stain for Prdm1 in the granular
layer of the epidermis and negative staining below. Scale bars, 5 mm (G); 10 mm (F); 20 mm (H and I). ****p , 0.0001.
1254 Prdm1 REGULATES mTEC FUNCTION
T cell development was not grossly impaired in these mice. In
addition, TCRb expression in CD4+ and CD8+ T cells from Prdm1
cKOK14 mice was as seen in control mice (Fig. 3L), suggesting
normal TCR expression. Normal T cell development also occurred
in Prdm1 cKOFoxN1 mice (Supplemental Fig. 2J–L).
Tregs develop within the thymus and require mTECs (4, 56–58).
To define whether the loss of epithelial Prdm1 expression resulted
in Treg developmental defects, we isolated thymocytes from
control, Prdm1 cKOK14, and Prdm1 cKOFoxN1 mice, stained them
for CD44, CD25, CD4, and Foxp3, and analyzed them by flow
cytometry (Fig. 4). Tregs (CD4+, CD44+, CD25+, Foxp3+) were
present in similar numbers in thymi from control, Prdm1 cKOK14,
and Prdm1 cKOFoxN1 mice (Fig. 4A, 4B). In addition, the levels of
CD25 and Foxp3 were comparable among control, Prdm1 cKOK14,
and Prdm1 cKOFoxN1 Tregs, suggesting normal development of
this population. Importantly, Tregs were also identified within
peripheral lymphoid tissues of Prdm1 cKOK14, Prdm1 cKOFoxN1,
and control mice (Fig. 4C, 4D). Taken together, these data suggest
that in the absence of Prdm1, the thymic epithelium develops
normally and is able to support a normal T cell developmental
program including Tregs.
Prdm1 functions in the thymus to regulate autoimmunity
To definitively ascertain whether autoimmunity associated with
epithelial deletion of Prdm1 was due to a role of Prdm1 within
TECs, we determined whether transplanted thymic epithelial tissue
FIGURE 3. Normal TEC and T cell
development in the absence of Prdm1.
(A) Representative flow cytometry
plots indicating the gating strategy
for CD452 cTECs (Ly51+EPCAM1+),
immature mTECs (Ly512EPCAM1+
CD802), and mature mTECs (Ly512
EPCAM1+CD80+) for both control
and Prdm1 cKOK14 thymus. (B–D)
Summary of the absolute cell num-
bers for each of the indicated epi-
thelial cell populations. n = 3 mice
for each genotype. (B) p . 0.9999,
(C) p = 0.7, (D) p = 0.7. (E) Repre-
sentative fluorescence images of
control and Prdm1 cKOK14 thymus
sections stained for (left) K5 (green),
K8 (red), and (right) MHCII (gray).
Scale bars, 100 mm. (F) mRNA ex-
pression of MHCII in FACS-isolated
control and Prdm1 cKOK14 mTECs.
Data are mean (6 SD) of at least
three independent experiments. (G)
Representative fluorescence images
of control and Prdm1 cKOK14 thymus
sections stained for K5 (red) and Aire
(green). Scale bars, 25 mm. (H) Quan-
tification of the number of Aire-positive
mTECs (K5+). n = 3 mice for each
genotype. (I) Quantitative real-time
PCR analysis of mRNA transcript
levels of Aire in control and Prdm1
cKOK14 mTECs. (J) Representative
CD4 and CD8 profiles from control
and Prdm1 cKOK14 thymocytes. (K)
Quantification of the total cell num-
bers for each thymocyte population of
CD4+ and CD8+ single-positive cells
and CD4+CD8+ double-positive cells.
(L) Histograms illustrating the ex-
pected upregulation of the TCRb with
thymocyte maturation. Data are mean
(B–D, H) or mean6 SD (F, I–K). n = 3
mice for each genotype. ns, not sig-
nificant.
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from Prdm1 cKOK14 mice could generate autoimmune pheno-
types. Thymus lobes from E15 littermate control and Prdm1
cKOK14 mice were treated with 2-deoxyguanosine and grafted
under the kidney capsule of 6- to 8-wk-old, male, Nude mice,
which lack T cells because of the absence of a functional thymus
(59) (Fig. 5A). Six weeks after engraftment, blood from Nude
host mice grafted with control or Prdm1 cKOK14 thymus under
the kidney capsule contained CD4+ and CD8+ T cells, as seen in
WT blood (Fig. 5B), confirming successful and functional en-
graftment (5). After 5 mo, thymic grafts from both control and
Prdm1 cKOK14 mice contained thymocytes expressing CD4 and
CD8 similar to WT thymus (Fig. 5C). Furthermore, the per-
centage of developing T cell populations, CD4+, CD8+ and CD4+
CD8+, were comparable between the hosts and WT mice
(Fig. 5D), indicating maintenance of the epithelial grafts and
confirming successful T cell development.
To determine whether thymi from Prdm1 cKOK14 mice were
sufficient to induce autoimmune phenotypes in Nude host mice,
we evaluated the serum of host mice for the presence of ANAs.
Although none of the mice engrafted with control thymi had
ANAs after 5 wk, 100% of the mice engrafted with thymi from
Prdm1 cKOK14 mice displayed ANAs (Fig. 5E, 5F). The pattern
of HEp2 nuclear staining was mostly homogeneous and speckled
(Fig. 5G), similar to that observed in the Prdm1 cKOK14 mice
(Fig. 1H). Furthermore, the sera of Nude mice engrafted with
control thymi did not contain elevated levels of IgG isotypes,
whereas the sera of Nude mice engrafted with Prdm1 cKOK14
thymi displayed elevated levels of IgG2b and IgG1 (Fig. 5H).
Both of these isotypes were also elevated in Prdm1 cKOK14 mice
(Fig. 1I) and are T cell dependent (60), suggesting a T cell–
mediated response in the autoimmune phenotype of the mice.
Recent work has suggested that expression of TSAs is coor-
dinated within populations of mTECs (38). To determine whether
Prdm1+ mTECs display unique gene expression patterns, we
performed an in silico analytical approach to assess the coex-
pression of genes within single-cell RNA sequencing data from
CD45–, Ly51lo, MHCIIhi, Aire-positive mTECs (52) (Supplemental
Fig. 3). Of the 200 cells analyzed, 24% of the cells displayed ex-
pression of Prdm1, supporting the expression of Prdm1 in a subset
of mTECs (Fig. 2B, Supplemental Fig. 3A). Furthermore, this
analysis demonstrated that Aire and Prdm1 are coexpressed within a
subset of mTECs. Prdm1 expression was detected in both WT and
Aire KO mTECs, which is consistent with similar levels of Prdm1
expression in Aire KO mice (Supplemental Fig. 3B).
Global analysis of gene expression in Prdm1+ mTECs revealed
distinct patterns of genes compared with Prdm1– mTECs
(Supplemental Fig. 3A). Spearman-rank correlation analysis
between Prdm1 and all expressed genes within the Meredith RNA-
sequencing dataset indicated that a predominant number of tran-
scripts were associated with Prdm1 expression (Supplemental Fig.
3C). We further filtered this gene set using a stringent cutoff of p #
0.0005 to identify robust Prdm1-associated genes (Supplemental
Fig. 3D, Supplemental Table I). To determine whether Prdm1 ex-
pression was correlated with TSA-associated gene expression
patterns in Aire+ mTECs, we compared Prdm1 expression with
previously defined Aire-dependent or Aire-independent genes
derived from three TSA-encoding genes: Tspan8, Ceacam1, and
Klk5 (38, 39). Interestingly, we found that Prdm1 was more sig-
nificantly linked with Aire-independent TSA-associated genes
than Aire-dependent TSA-associated genes or all expressed genes
(Supplemental Fig. 3E, 3F, Supplemental Table I). In addition,
Prdm1 and Aire did not correlate with each other (rho = 0.07, p =
0.162). Together, these data suggest that Prdm1+ mTECs represent a
unique subset of mTECs important in the prevention of autoimmunity.
Discussion
Our study has revealed a novel mechanism for TEC function via
the transcription factor Prdm1. It is intriguing to speculate that
Prdm1 regulates TEC function by regulating TSA expression in a
subset of TECs either in coordination or independently from the
transcription factor Aire. Perhaps, Prdm1 creates some of the
epigenetic markers that Aire is thought to recognize to enable
Aire’s subsequent activity (61–63). Our in silico analysis of gene
expression in single mTECs reveals that Prdm1 may regulate a
subset of TSAs and in particular, Aire-independent TSAs. Other
studies have indicated distinct functions of Aire in a cell type–
dependent manner (6, 64, 65).
Prdm1 and its human ortholog PRDI-BF1 elicit their tran-
scriptional modulation by several different mechanisms, includ-
ing direct competition for DNA binding (66) and recruitment of
FIGURE 4. Spontaneous development of autoimmunity is not the re-
sult of an absence of Tregs. (A–C) Representative flow cytometric plots
showing CD44+CD4+CD25+Foxp3+ Tregs in thymus and cervical
(mandibular and accessory mandibular) lymph nodes. Note the levels of
Foxp3 and CD25 are similar in control, Prdm1 cKOK14, and Prdm1 cKOFoxN1.
(B) Absolute cell numbers of Tregs found within the thymus are not sig-
nificantly different between control and cKO mice. (D) Absolute cell
numbers of Tregs found within the cervical lymph node suggest an increase
in cKO mice compared with control. Data are mean. n $ 3 mice for each
genotype; each point represents an individual mouse. *p = 0.0159. ns, not
significant.
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FIGURE 5. Transplantation of Prdm1 cKOK14 thymic stroma leads to autoimmunity. Representative flow cytometry analysis of blood CD4 and CD8
T cells in WTand Nude mice prior to transplantation (A) or 6 wk after grafting of control or Prdm1 cKOK14 embryonic (E15) thymus lobes under the kidney
capsule (B). (C) Analysis of CD4 and CD8 T cell development in the grafted thymic epithelial tissue after 5 mo revealed T cell profiles similar to those in
WT thymus. (D) Quantification of percentage of T cell subsets between control and Prdm1 cKOK14 grafts. Each bar represents three or more independently
analyzed thymic grafts harvested from a single host. (E) Compared with serum isolated from control host mice, Prdm1 cKOK14 host serum contains ANAs
as indicated by positive staining of HEp2 cells. Representative images from sera derived from one host, engrafted with thymi from control, or two hosts
engrafted with thymi from Prdm1 cKOK14 mice. Scale bars, 50 mm. (F) The presence of ANAs is more frequent in Prdm1 cKOK14 host mice compared with
control. (G) Homogenous and speckled nuclear staining patterns were observed from sera isolated from mice engrafted with thymi from Prdm1 cKOK14
mice. (H) ELISA of serum Ab isotypes after 5 wk of engraftment. Note the increase in IgG2b and IgG1 in Prdm1 cKOK14 serum compared with control
serum. Data are mean. n = 4 grafted mice for each genotype of transplanted thymi. *p , 0.05.
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corepressor proteins such as the Groucho family that function in
part through association with HDACs (12, 67). Prdm1 has been
shown to interact with several chromatin-modifying proteins, for
example, G9a lysine methyltransferase (10), HDAC1/2 (13), protein
arginine methyltransferase 5 (68), and lysine deacetylase 1 (69).
Thus, it seems possible that PRDI-BF1 might act as a DNA-
binding scaffold protein capable of directly recruiting multiple
chromatin-modifying enzymes to targeted promoters (10). Inter-
estingly, Prdm1 is associated with HDAC5 expression in individual
mTECs, and although further validation of this interaction remains
an opportunity for future study, this may provide an additional
epigenetic mechanism for regulation of TSAs and a novel inter-
action for Prdm1.
Furthermore, although Prdm1 is most commonly known as a
transcriptional repressor, it has been identified in transcriptional
activation (16, 70). Therefore, it is possible that Prdm1 could
be directly promoting TSA expression; the exact mechanism
by which Prdm1 controls TEC function will be an interesting area
of future study.
Mice lacking Prdm1 in epithelial cells develop chronic skin
inflammation, which is thought to be due to defects in epidermal
barrier immunity (31, 32). Until now, these observations have
precluded the analysis of Prdm1’s role in the thymic epithelium.
We find that Prdm1 is expressed within the medullary thymic
epithelium and Hassall’s corpuscles, which are thought to repre-
sent the terminally differentiated epithelial compartment within
the thymus (55). This is consistent with Prdm1’s expression in the
most differentiated layers of the skin epidermis (26). Although the
function of Hassall’s corpuscles has not been fully explored, they
are thought to be involved in removing dead thymocytes, matu-
ration of medullary thymocytes (71, 72), and education of den-
dritic cells during Treg development (73). Because thymus tissue
from immunodeficient patients lacks Hassall’s corpuscles (74, 75),
it is exciting to speculate that these structures play a role in
establishing tolerance. It will be interesting to determine whether
Prdm1 could be a therapeutic target to maintain thymic function in
these patients.
Intriguingly, Prdm1 does not affect mTEC development, as
indicated by its expression within the most differentiated cell types
within the thymus and by the absence of a defect in the epithelial
compartment of the Prdm1 cKOK14 and Prdm1 cKOFoxN1 thymus.
Together with the absence of an identified association with HDAC3
in the global analysis of gene expression, these data suggest that
Prdm1 works independently of HDAC3, which has recently been
reported to be a master regulator of mTEC development and im-
portant for epigenetic regulation of Prdm1 in B lymphocytes (76, 77).
Slightly different phenotypes are observed between the Prdm1
cKOK14 and cKOFoxN1 mouse models. Although the reasons for
these differences remain unclear, it is important to note that the
timing and pattern of expression of Cre in the K14Cre mouse is
not well defined, despite both strains being frequently used as
models to delete genes from total thymic epithelium. Furthermore,
Foxn1 is comprised of eight coding exons and utilizes two alter-
native first exons in a tissue-specific fashion (78, 79); therefore, it
is conceivable that FoxN1cre activity remains absent from the
skin after birth (80), whereas it is possible that the K14cre is
active within the skin.
Importantly, Prdm1 cKOK14 thymus transplantation demon-
strates that Prdm1 deficiency in thymic epithelium is sufficient to
elicit a breakdown in thymic tolerance because this model enabled
the role of Prdm1 in thymic epithelium to be separated from its
known role within skin epidermis (27, 32). With functional Prdm1
in the epidermis, hosts that received Prdm1-deficient thymus lobes
developed ANAs. However, it was intriguing that, despite this,
other phenotypes observed in the cKOK14, such as cervical lymph-
adenopathy, were not observed. Perhaps this could be attributable
to a previously undetermined role for Prdm1 in other barrier epithelial
tissues, promoting their functional integrity and homeostasis, such as
the tongue and esophagus, where the activity of the K14 promoter has
been identified (81); further investigation would be required to clarify
this. In addition, impaired containment of the commensal microflora
at these sites could explain the local inflammation resulting in en-
larged cervical lymph nodes.
Because it is known that Prdm1 negatively regulates the ex-
pression of CIITA, a transcription factor that regulates MHCII
gene expression (82), and that TSA expression is dependent on
MHC expression levels, it was critical to check the protein and
mRNA expression levels of MHCII; these did not differ between
control and Prdm1 cKOK14 mice, ruling out a dysregulation of
MHCII in the autoimmune phenotype presented by these mice. In
addition, it was important to decipher whether Prdm1 was an Aire-
regulated gene. To do this, we analyzed mTECs from both WTand
Aire KO for Prdm1 expression, which was detected at similar
levels in both WT and Aire KO mTECs (Supplemental Fig. 3F),
implying that Prdm1 is not an Aire-dependent gene.
Despite the ability of mTECs and Hassall’s corpuscles to direct
Treg development (4, 56–58, 73), loss of Prdm1 in epithelial cells
did not alter Treg development or export to the periphery because
comparable numbers within both the thymus and the peripheral
lymph nodes were identified in control and Prdm1 cKOK14 and
Prdm1 cKOFoxN1 mice. This suggests that the autoimmune phe-
notype that presented in Prdm1 cKO mice was not due to an ab-
sence of immune regulation and that Prdm1 null mTECs are
unable to efficiently delete self-reactive T cells.
Interestingly, polymorphisms in Prdm1 are associated with
autoimmune diseases, such as SLE (33, 34). Importantly, dermatitis
(83, 84), hypergammaglobulinemia, and kidney immune complex
deposition are frequently used as diagnostic markers for SLE.
Furthermore, ANAs (50), particularly the homogenous and speckled
patterns, are prevalent within patients with SLE (85). Importantly,
we show that Prdm1 cKOK14 mice develop SLE-associated symp-
toms, including ANAs, hypergammaglobulinemia, and kidney
immune complex deposition, suggestive of glomerulonephritis
(33, 83, 84, 86), and previous studies reported the dermatitis
using the K14-Cre and K5-Cre mouse models (31, 32). Together,
these data raise the interesting possibility that SLE may be driven by
a breakdown in thymic tolerance, and the data are consistent with a
role for Prdm1 in SLE. Of relevance, we show that the autoanti-
bodies produced in Prdm1 cKOK14 and Prdm1 cKOFoxN1 mice are
the T cell–dependent isotypes, IgG2b and IgG1 (60). This high-
lights the requirement of T cell help for Ab production in this
model, consistent with a T cell component in activating autoreactive
B cells in SLE.
Collectively, our findings show that despite Prdm1 being expressed
within the medullary thymic epithelium, particularly the Hassall’s
corpuscles, it does not regulate mTEC development and does not
alter T cell development including intrathymic Treg development.
The absence of Prdm1 from the thymic epithelium does, however,
result in an autoimmune-like phenotype that manifests as the pre-
sentation of ANAs and hypergammaglobulinemia that is transfer-
able by transplantation of Prdm1 cKO thymus lobes into Nude
hosts, uncoupling the role of Prdm1 in the skin epithelium from
being the sole reason for the phenotype presented by cKO mice.
Furthermore, our data present the possibility that Prdm1 is involved
in the regulation of Aire-independent TSA expression within the
thymus, thus adding another dimension to the association of Prdm1
mutations with autoimmune disorders such as SLE (33), rheumatoid
arthritis (87), and Crohn’s disease (88).
1258 Prdm1 REGULATES mTEC FUNCTION
Acknowledgments
We thank Nancy Manley for FoxN1-Cre mice and Elaine Fuchs for the
K14-Cre mice. Members of the Horsley and Kaech Laboratories provided
valuable discussions, and Jason Weinstein and Joseph Craft offered help
and the regents required for the ELISAs. We thank Adrian Hayday for
expert counsel, Andrea White for guidance with flow cytometry gating
strategies, and Karin Loser for advice regarding kidney Ig staining.
Disclosures
The authors have no financial conflicts of interest.
References
1. Kyewski, B., and L. Klein. 2006. A central role for central tolerance. Annu. Rev.
Immunol. 24: 571–606.
2. Derbinski, J., A. Schulte, B. Kyewski, and L. Klein. 2001. Promiscuous gene
expression in medullary thymic epithelial cells mirrors the peripheral self. Nat.
Immunol. 2: 1032–1039.
3. Lei, Y., A. M. Ripen, N. Ishimaru, I. Ohigashi, T. Nagasawa, L. T. Jeker,
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